Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4567259
Max Phase: Preclinical
Molecular Formula: C26H34N4O6
Molecular Weight: 498.58
Molecule Type: Unknown
Associated Items:
ID: ALA4567259
Max Phase: Preclinical
Molecular Formula: C26H34N4O6
Molecular Weight: 498.58
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(O)C(=O)NCc1ccccc1
Standard InChI: InChI=1S/C26H34N4O6/c1-17(2)13-21(30-26(35)36-16-19-11-7-4-8-12-19)24(33)29-20(14-22(27)31)23(32)25(34)28-15-18-9-5-3-6-10-18/h3-12,17,20-21,23,32H,13-16H2,1-2H3,(H2,27,31)(H,28,34)(H,29,33)(H,30,35)/t20-,21-,23?/m0/s1
Standard InChI Key: WRDSLXQVNSZWEG-MMBKUXRPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 498.58 | Molecular Weight (Monoisotopic): 498.2478 | AlogP: 1.37 | #Rotatable Bonds: 13 |
Polar Surface Area: 159.85 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.40 | CX Basic pKa: | CX LogP: 1.36 | CX LogD: 1.36 |
Aromatic Rings: 2 | Heavy Atoms: 36 | QED Weighted: 0.28 | Np Likeness Score: -0.25 |
1. Pacifico S, Ferretti V, Albanese V, Fantinati A, Gallerani E, Nicoli F, Gavioli R, Zamberlan F, Preti D, Marastoni M.. (2019) Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors., 10 (7): [PMID:31312413] [10.1021/acsmedchemlett.9b00233] |
Source(1):